METROPOLITAN LIFE INSURANCE CO/NY - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 77 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q4 2015$152,000
-41.3%
114,066
+0.3%
0.00%
-50.0%
Q3 2015$259,000
+65.0%
113,678
+16.6%
0.00%
+100.0%
Q2 2015$157,000
-24.9%
97,453
-25.9%
0.00%
-50.0%
Q1 2015$209,000
-16.4%
131,489
-0.4%
0.00%0.0%
Q4 2014$250,000
+43.7%
132,0570.0%0.00%
+100.0%
Q3 2014$174,000
+5700.0%
132,057
+7502.6%
0.00%
Q2 2014$3,000
-98.4%
1,737
-98.3%
0.00%
-100.0%
Q1 2014$189,000
-10.4%
102,0040.0%0.00%0.0%
Q4 2013$211,000
-21.9%
102,0040.0%0.00%
-50.0%
Q3 2013$270,000
+103.0%
102,004
+104.8%
0.00%
+100.0%
Q2 2013$133,00049,8140.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2013
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders